Gritstone bio – a company focused on developing global vaccinations – has revealed that it has established a clinical trial partnership with the National Cancer Institute (NCI).
Purple Biotech is adding Immunorizon’s tri-specific antibodies to its paint palette in an acquisition that could reach $100 million.
Market Place
Share
Purple Biotech News Full Screen View
Share
